Galectin Therapeutics Inc (GALT)

2.710
+0.050(+1.88%)
  • Volume:
    252,628
  • Bid/Ask:
    2.710/2.720
  • Day's Range:
    2.630 - 2.740

GALT Overview

Prev. Close
2.66
Day's Range
2.63-2.74
Revenue
-
Open
2.65
52 wk Range
1.82-5.69
EPS
-0.46
Volume
252,628
Market Cap
159.18M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,581,457
P/E Ratio
-
Beta
2.29
1-Year Change
-3.97%
Shares Outstanding
58,094,788
Next Earnings Date
Aug 12, 2021
What is your sentiment on Galectin Therapeutics Inc?
or
Vote to see community's results!

Galectin Therapeutics Inc News

Galectin Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell

Galectin Therapeutics Inc Company Profile

Galectin Therapeutics Inc Company Profile

Employees
6

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company’s lead product candidate is (GR-MD-02) belapectin galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Read More
  • wondering if this is a long play...i got in @3.79
    1
    • Any thoughts??
      0
      • was waiting long time to buy.. now paid too much
        0
        • Earning reports is like the beginning of a Dubstep song. Waiting for the beat to drop.
          0
          • Update on my short, still ITM
            0
            • Just took a short position, lets see how ignorant I was!
              0
              • RIP
                0
            • Just closed my position. It was a good deal
              0
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.